Biomedical Institute for Global Health Research and Technology (BIGHEART) at NUS and Holmusk Partner to Innovate Healthcare IT for Chronic Disease

USA - English

• USA - English

SINGAPORE, March 27, 2017 /PRNewswire/ -- The National University of Singapore (NUS) and Holmusk, a digital health and data analytics company, signed a Memorandum of Understanding (MOU) recently to explore collaborations for improving healthcare delivery in the region.

Under this MOU, the Biomedical Institute for Global Health Research and Technology (BIGHEART) at NUS and Holmusk will establish a working relationship on several topics related to healthcare IT and medical device development. These include personal informatics and intervention through healthcare applications, such as mobile food logging, diabetes management and mental health. Another area to be explored is the analysis of personal health data from surveys, smart phones and wearables, electronic medical records and other clinical data.

"There are many critical healthcare challenges faced by both developed and developing countries today," said Professor Luke P. Lee, founding director of BIGHEART at NUS. "This collaboration will allow us to take our interdisciplinary research further, by collaborating with Holmusk on apps, digital technology and predictive analytics. Together, we believe we can move closer towards overcoming some of the technical barriers that prevent good healthcare in the region.

"BIGHEART at NUS is at the forefront of basic and translational healthcare research. We are excited to lend our digital health and data analytics experience and capabilities to these projects, in order to commercialise and bring pioneering research to the region in a practical and sustainable manner," said Nawal Roy, CEO and Founder of Holmusk.

For media enquiries, please contact:

For BIGHEART
Sasha Taylor
Communications Manager
BIGHEART, Biomedical Institute for Global Health Research & Technology, NUS 
Tel: +65 6601 5388
Email: [email protected]

For Holmusk
Yuree Hong 
Marketing Lead, Holmusk
Tel: +65 6250 4233 
Email: [email protected]  

About National University of Singapore (NUS)

A leading global university centred in Asia, the National University of Singapore (NUS) is Singapore's flagship university, which offers a global approach to education and research, with a focus on Asian perspectives and expertise.

NUS has 17 faculties and schools across three campuses. Its transformative education includes a broad-based curriculum underscored by multi-disciplinary courses and cross-faculty enrichment. Over 38,000 students from 100 countries enrich the community with their diverse social and cultural perspectives.

NUS has three Research Centres of Excellence (RCE) and 30 university-level research institutes and centres. It is also a partner in Singapore's fifth RCE. The University has established many research partnerships and joint laboratories with academic institutions, industry leaders and government agencies. Research activities are strategic and robust, and NUS is well-known for its research strengths in engineering, life sciences and biomedicine, social sciences and natural sciences. The University also strives to create a supportive and innovative environment to promote creative enterprise within its community.  

For more information on NUS, visit www.nus.edu.sg.

About BIGHEART

BIGHEART was established in 2016 at the National University of Singapore (NUS). BIGHEART conducts interdisciplinary research to address the technical barriers preventing distributed global healthcare solutions. Our mission is to transform research and education and shape the future of healthcare by the creative convergence of life sciences, physical sciences, engineering, medicine, and the arts for innovative healthcare technologies. For more information visit BIGHEART.nus.edu.sg 

About Holmusk

Holmusk is a global digital health and data analytics company, focused on solving complex problems in healthcare for chronic diseases. We build innovative, scalable and cost-effective digital behaviour change programs that combine cutting-edge clinical research, technology and design to nudge people towards sustainable changes for better health. We develop powerful predictive algorithms that offer actionable insights for personalised care and population health management. We are based in Singapore, Malaysia and USA. For more information on Holmusk, visit www.holmusk.com

SOURCE Holmusk